PATENT CLAIM ANALYSIS

Application Number: 15976808
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.

Claim (Index 61):
An oral dosage form in the form of a capsule which comprises: 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition; 2) a binder or filler at an amount of 90 to 99 weight percent of total weight of the composition, wherein the binder or filler is starch, mannitol or a mixture thereof.

Metadata:
- Claim Count in Document: 170.0
- Percentile: 93.0
- Lexical Diversity: 1.39024
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14998262', '12783390', '11384381', '14508719', '10608077']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7655026872104097
- 35 USC 102 Novelty (BERT): 0.5400371753227852
- Combined Prediction Score: 0.7429561360216472
- Mean Citation Score: 325.040406
- Max Citation Score: 376.8725
- Similarity Product: 330.241547473073

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test